These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39138826)

  • 1. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment.
    Tobaruela-Resola AL; Milagro FI; Elorz M; Benito-Boillos A; Herrero JI; Mogna-Peláez P; Tur JA; Martínez JA; Abete I; Zulet MÁ
    J Physiol Biochem; 2024 Aug; ():. PubMed ID: 39138826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention.
    Tobaruela-Resola AL; Riezu-Boj JI; Milagro FI; Mogna-Pelaez P; Herrero JI; Elorz M; Benito-Boillos A; Tur JA; Martínez JA; Abete I; Zulet MA
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.
    Correia de Sousa M; Delangre E; Berthou F; El Harane S; Maeder C; Fournier M; Krause KH; Gjorgjieva M; Foti M
    JHEP Rep; 2024 Sep; 6(9):101126. PubMed ID: 39263327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
    J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial.
    Mogna-Peláez P; Riezu-Boj JI; Milagro FI; Herrero JI; Elorz M; Benito-Boillos A; Tobaruela-Resola AL; Tur JA; Martínez JA; Abete I; Zulet MA
    Clin Nutr; 2024 Jul; 43(7):1770-1781. PubMed ID: 38861890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression.
    Wu LF; Zhou ZJ; Zeng YH; Yang SL; Zhang QY
    Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G485-G498. PubMed ID: 39259911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader-Willi Syndrome and Non-Syndromic Obesity.
    Pratama MY; Pascut D; Tamini S; Minocci A; Tiribelli C; Grugni G; Sartorio A
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study.
    Iacomino G; Russo P; Marena P; Lauria F; Venezia A; Ahrens W; De Henauw S; De Luca P; Foraita R; Günther K; Lissner L; Molnár D; Moreno LA; Tornaritis M; Veidebaum T; Siani A
    Genes Nutr; 2019; 14():2. PubMed ID: 30651891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat.
    Quintás G; Caiment F; Rienda I; Pérez-Rojas J; Pareja E; Castell JV; Jover R
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.
    Crudele L; De Matteis C; Novielli F; Di Buduo E; Petruzzelli S; De Giorgi A; Antonica G; Berardi E; Moschetta A
    Biol Sex Differ; 2024 May; 15(1):43. PubMed ID: 38760802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.
    López-Riera M; Conde I; Tolosa L; Zaragoza Á; Castell JV; Gómez-Lechón MJ; Jover R
    Front Pharmacol; 2017; 8():3. PubMed ID: 28179883
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance.
    Johnson K; Leary PJ; Govaere O; Barter MJ; Charlton SH; Cockell SJ; Tiniakos D; Zatorska M; Bedossa P; Brosnan MJ; Cobbold JF; Ekstedt M; Aithal GP; Clément K; Schattenberg JM; Boursier J; Ratziu V; Bugianesi E; Anstee QM; Daly AK; ;
    JHEP Rep; 2022 Feb; 4(2):100409. PubMed ID: 35072021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
    Tavaglione F; Flagiello V; Terracciani F; Gallo P; Capparelli E; Spiezia C; De Vincentis A; Palermo A; Scriccia S; Galati G; Napoli N; Daniels SJ; Blau JE; Carlsson B; Khazrai YM; Incalzi RA; Picardi A; Vespasiani-Gentilucci U
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3787. PubMed ID: 38461408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy.
    Soluyanova P; Del Pozo M; Moro-Castaño E; Marco-Hernández AV; Castell JV; Jover R
    Toxicology; 2024 Oct; 509():153974. PubMed ID: 39423997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
    Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
    BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD.
    Abdelhameed F; Kite C; Lagojda L; Dallaway A; Chatha KK; Chaggar SS; Dalamaga M; Kassi E; Kyrou I; Randeva HS
    Curr Obes Rep; 2024 Sep; 13(3):510-531. PubMed ID: 38809396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD.
    López-Sánchez GN; Montalvo-Javé E; Domínguez-Perez M; Antuna-Puente B; Beltrán-Anaya FO; Hidalgo-Miranda A; Chávez-Tapia NC; Uribe M; Nuño-Lámbarri N
    Ann Hepatol; 2022; 27(6):100756. PubMed ID: 36096296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-derived exosomes from obstructive sleep apnoea rats aggravate MASLD by TCONS_00039830/miR-455-3p/Smad2 axis.
    Yang L; He Y; Liu S; Gan L; Ni Q; Dai A; Mu C; Liu Q; Chen H; Lu H; Sun R
    Commun Biol; 2024 Apr; 7(1):492. PubMed ID: 38654054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.